Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Tue 28 Oct 2008, 10:38 MDC - Medi-Clinic - Trading Statement
MDC
MDC                                                                             
MDC - Medi-Clinic - Trading Statement                                           
MEDI-CLINIC CORPORATION LIMITED                                                 
(Incorporated in the Republic of South Africa)                                  
(Registration number: 1983/010725/06)                                           
(Share code: MDC)                                                               
(ISIN: ZAE000074142)                                                            
("Medi-Clinic" or "the Company")                                                
TRADING STATEMENT                                                               
The operational performance of Medi-Clinic for the six months ended 30 September
2008 is consistent with historical performance and expectations and is not the  
subject of this trading statement.                                              
In terms of paragraph 3.4(b) of the JSE Limited ("JSE") Listings Requirements,  
companies are required to publish a trading statement as soon as they become    
reasonably certain that the financial results for the period to be reported upon
next will differ by at least 20% from that of the previous corresponding period.
Medi-Clinic is currently finalising its results for the six months ended 30     
September 2008, which are due to be released on SENS on 5 November 2008 and     
published in the press on 6 November 2008.                                      
Shareholders are referred to the circular to shareholders dated 17 August 2007  
("the circular") presenting details relating to the acquisition of the          
Hirslanden private hospital group in Switzerland, which transaction became      
effective on 26 October 2007 (the "Hirslanden acquisition") and the rights offer
of 198.7 million Medi-Clinic shares, effected in December 2007 (the "rights     
offer"). The unaudited pro forma financial effect of the Hirslanden acquisition 
and the rights offer on the earnings per share ("EPS") and the headline EPS     
("HEPS") of the Company was fully disclosed in the circular.                    
In compliance with the JSE Listings Requirements, shareholders are advised that 
the Company`s EPS and HEPS for the six months ended 30 September 2008 will be   
between 40% and 45% lower than that reported for the previous corresponding     
reporting period, mainly as a result of the increased weighted number of        
ordinary shares in issue pursuant to the rights offer.                          
The financial information on which this trading statement is based has not been 
reviewed and reported on by the Company`s auditors.                             
Stellenbosch                                                                    
28 October 2008                                                                 
Sponsor                                                                         
RAND MERCHANT BANK (A division of FirstRand Bank Limited)                       
Date: 28/10/2008 10:38:47 Produced by the JSE SENS Department.                  
The SENS service is an information dissemination service administered by the    
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or            
implicitly, represent, warrant or in any way guarantee the truth, accuracy or   
completeness of the information published on SENS. The JSE, their officers,     
employees and agents accept no liability for (or in respect of) any direct,     
indirect, incidental or consequential loss or damage of any kind or nature,     
howsoever arising, from the use of SENS or the use of, or reliance on,          
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
[  Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: